Alpha DNA Investment Management’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-39,921
Closed -$5.02M 110
2024
Q4
$5.02M Buy
39,921
+21,090
+112% +$2.6M 1.91% 5
2024
Q3
$1.96M Sell
18,831
-27,376
-59% -$2.76M 0.73% 28
2024
Q2
$4.49M Buy
46,207
+23,387
+102% +$2.23M 1.74% 4
2024
Q1
$2.15M Buy
22,820
+10,899
+91% +$960K 0.79% 18
2023
Q4
$1.11M Buy
11,921
+52
+0.4% +$4.16K 0.43% 41
2023
Q3
$969K Sell
11,869
-14,051
-54% -$1.22M 0.4% 49
2023
Q2
$2.21M Buy
25,920
+6,186
+31% +$529K 0.74% 17
2023
Q1
$1.73M Buy
19,734
+9,440
+92% +$881K 0.51% 26
2022
Q4
$875K Buy
10,294
+2,524
+32% +$215K 0.31% 138
2022
Q3
$613K Buy
+7,770
New +$655K 0.51% 79
2021
Q2
Sell
-368
Closed -$27K 432
2021
Q1
$27K Sell
368
-2
-0.5% -$153 0.03% 227
2020
Q4
$25K Buy
+370
New +$21.2K 0.03% 241

Other funds holding MS

Alpha DNA Investment Management's MS Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Morgan Stanley (MS) in Q1 2025, closing a stake of 39,921 shares — an estimated $5.02M sold.

Alpha DNA Investment Management first reported a position in MS in Q4 2020 and held it in 12 quarters. The position peaked at $5.02M in Q4 2024. 2,099 funds tracked by Wall St. Rank hold MS as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Morgan Stanley position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 39,921 Morgan Stanley shares in Q1 2025, an estimated $5.02M.
  • Alpha DNA Investment Management first reported a position in Morgan Stanley in Q4 2020 and held it in 12 quarters.
  • Alpha DNA Investment Management's Morgan Stanley position peaked at $5.02M in Q4 2024.
  • 2,099 funds tracked by Wall St. Rank held Morgan Stanley as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.